Charles Nguyen

Assistant Clinical Professor

City Of Hope National Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Artificial Intelligence Artificial Intelligence professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Charles Nguyen is an Assistant Clinical Professor at City Of Hope National Medical Center in the United States. His research focuses on advanced cancer treatment modalities, including the investigation of novel therapies for metastatic castration-resistant prostate cancer and the application of artificial intelligence in cancer risk stratification. Recent publications highlight his work on treatment-related outcomes in urological cancers and the genetic landscape of renal cell carcinoma.

Articles (8)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2020

Collaborators (2)

Pavlos Msaouel

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Jonathan Chou

Assistant Professor

University of California, San Francisco

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Charles Nguyen

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Treatment‐Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study

Multicenter Phase II Study of Olaparib and the ATR Inhibitor Ceralasertib in Metastatic Castration-Resistant Prostate Cancer (TRAP)

Leveraging Artificial Intelligence to Improve Risk Stratification in Nonmetastatic Castration-Resistant Prostate Cancer

Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial

Novel Approaches with HIF-2α Targeted Therapies in Metastatic Renal Cell Carcinoma

Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System

Pathogenic Germline Mutational Landscape in Patients With Renal Cell Carcinoma and Associated Clinicopathologic Features

Primary bone lymphoma of the ilium successfully treated without radiation

Collaborators (2)

Pavlos Msaouel

Jonathan Chou

Make your next move.